| 前收市價 | 321.20 |
| 開市 | 321.60 |
| 買盤 | 300.00 x 無 |
| 賣出價 | 330.00 x 無 |
| 今日波幅 | 320.90 - 325.90 |
| 52 週波幅 | 306.80 - 357.65 |
| 成交量 | |
| 平均成交量 | 26,468,933 |
| 市值 | 29.753B |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 29.62 |
| 每股盈利 (最近 12 個月) | 0.11 |
| 業績公佈日 | 2024年2月29日 |
| 遠期股息及收益率 | 0.06 (1.87%) |
| 除息日 | 2024年3月14日 |
| 1 年預測目標價 | 363.53 |
ZacksPharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
ZacksGSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
ZacksPfizer (PFE) to Decrease Stake in Haleon From 32% to 24%
Pfizer (PFE) plans to sell some shares of consumer healthcare firm Haleon (HLN), which it owns, to bring down its stake from 32% to 24%.
